Medeor Therapeutics
CA - South SFBiotechnology
Focus: Medeor Therapeutics is a cellular immunotherapy biotech focused on kidney transplant rejection and infectious diseases. The company is early-stage with a focused pipeline in nephrology and immune tolerance.
Profile data last refreshed 2d ago · AI intelligence enriched 1w ago
Open Jobs
0
About Medeor Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Medeor Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MDR product
Immune ToleranceClinical Trials (1)
NCT05010174Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products
N/AHelp build intelligence for Medeor Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.